MIIT Urges Accelerated Breakthroughs in Core Technologies to Strengthen Pharmaceutical Supply Chain Resilience

Stock News
Oct 29

On October 28, 2025, the Consumer Goods Industry Department of China's Ministry of Industry and Information Technology (MIIT) convened a symposium in Nanchang, Jiangxi Province, focusing on pharmaceutical industry management and key supply chain initiatives.

The meeting emphasized that the Fourth Plenary Session of the 20th CPC Central Committee has charted the course for high-quality development of the pharmaceutical industry during the 15th Five-Year Plan period and beyond. Participants stressed the need to thoroughly implement the plenum's decisions, accurately assess domestic and international developments, and consolidate the sector's stabilizing recovery trend.

Key priorities include accelerating breakthroughs in core technologies, enhancing pharmaceutical supply chain resilience and security, boosting innovation in drugs and medical devices, and better meeting growing public health demands. The industry must accelerate its transformation from scale expansion to innovation-driven growth.

The symposium addressed multiple work tasks, including pharmaceutical industry operations, statistical surveys, high-quality supply chain development, and formulation of the 15th Five-Year Plan for the sector. Representatives from regional industry regulators, industry associations, and supporting institutions attended.

Participants agreed to improve working mechanisms, strengthen statistical foundations with verified data, and adopt systematic approaches to plan the 15th Five-Year Plan development path. The meeting called for cultivating new productive forces in pharmaceuticals based on regional advantages, enhancing industry-academia-research collaboration, and promoting best practices in innovation commercialization.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10